Sharing successes, challenges and daily happenings in the Department of Medicine
ARTICLE: Operational Recommendations for Scarce Resource Allocation in a Public Health Crisis AUTHORS: Michael R Ehmann, Elizabeth K Zink, Amanda B Levin, Jose I Suarez, Harolyn M E Belcher, Elizabeth… Read More »Operational Recommendations for Scarce Resource Allocation in a Public Health Crisis
ARTICLE: PGC1/PPAR drive cardiomyocyte maturation at single cell level via YAP1 and SF3B2 AUTHORS: Sean A Murphy, Matthew Miyamoto, Anaïs Kervadec, Suraj Kannan, Emmanouil Tampakakis, Sandeep Kambhampati, Brian Leei Lin, Sam Paek, Peter… Read More »PGC1/PPAR drive cardiomyocyte maturation at single cell level via YAP1 and SF3B2
ARTICLE: Dolutegravir-based Antiretroviral Therapy for Patients Coinfected With Tuberculosis and Human Immunodeficiency Virus: A Multicenter, Noncomparative, Open-label, Randomized Trial AUTHORS: Kelly E Dooley, Richard Kaplan, Noluthando Mwelase, Beatriz… Read More »Dolutegravir-based Antiretroviral Therapy for Patients Coinfected With Tuberculosis and Human Immunodeficiency Virus: A Multicenter, Noncomparative, Open-label, Randomized Trial
ARTICLE: Go Red for Women Strategically Focused Research Network: Summary of Findings and Network Outcomes AUTHORS: Marie-Pierre St-Onge, Brooke Aggarwal, Matthew A Allison, Jeffrey S Berger, Sheila F Castañeda, Janet… Read More »Go Red for Women Strategically Focused Research Network: Summary of Findings and Network Outcomes
ARTICLE: Four-Week Direct-Acting Antiviral Prophylaxis for Kidney Transplantation From Hepatitis C-Viremic Donors to Hepatitis C-Negative Recipients: An Open-Label Nonrandomized Study AUTHORS: Christine M Durand, Brittany Barnaba, Sile… Read More »Four-Week Direct-Acting Antiviral Prophylaxis for Kidney Transplantation From Hepatitis C-Viremic Donors to Hepatitis C-Negative Recipients: An Open-Label Nonrandomized Study
ARTICLE: Once-weekly rifapentine and isoniazid for tuberculosis prevention in patients with HIV taking dolutegravir-based antiretroviral therapy: a phase 1/2 trial AUTHORS: Kelly E Dooley, Radojkam Savic, Akshay… Read More »Once-weekly rifapentine and isoniazid for tuberculosis prevention in patients with HIV taking dolutegravir-based antiretroviral therapy: a phase 1/2 trial
ARTICLE: QT effects of bedaquiline, delamanid, or both in patients with rifampicin-resistant tuberculosis: a phase 2, open-label, randomised, controlled trial AUTHORS: Kelly E Dooley, Susan L… Read More »QT effects of bedaquiline, delamanid, or both in patients with rifampicin-resistant tuberculosis: a phase 2, open-label, randomised, controlled trial
ARTICLE: Association of Missense Mutation in FOLH1 With Decreased NAAG Levels and Impaired Working Memory Circuitry and Cognition AUTHORS: Caroline F Zink, Peter B Barker, Akira Sawa, Daniel… Read More »Association of Missense Mutation in FOLH1 With Decreased NAAG Levels and Impaired Working Memory Circuitry and Cognition
ARTICLE: Patient Trajectories Among Persons Hospitalized for COVID-19 : A Cohort Study AUTHORS: Brian T Garibaldi, Jacob Fiksel, John Muschelli, Matthew L Robinson, Masoud Rouhizadeh, Jamie Perin, Grant Schumock, Paul Nagy, Josh H… Read More »Patient Trajectories Among Persons Hospitalized for COVID-19 : A Cohort Study
ARTICLE: Development of Severe COVID-19 Adaptive Risk Predictor (SCARP), a Calculator to Predict Severe Disease or Death in Hospitalized Patients With COVID-19 AUTHORS: Shannon Wongvibulsin,… Read More »Development of Severe COVID-19 Adaptive Risk Predictor (SCARP), a Calculator to Predict Severe Disease or Death in Hospitalized Patients With COVID-19